| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia
|
Keats, Julian
|
|
2015
|
|
10 |
p. 999-1006
8 p.
|
artikel
|
| 2 |
Beyond viral response: A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of HCV treatment and support
|
Mason, Kate
|
|
2015
|
|
10 |
p. 1007-1013
7 p.
|
artikel
|
| 3 |
Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs
|
Larney, Sarah
|
|
2015
|
|
10 |
p. 950-957
8 p.
|
artikel
|
| 4 |
Enhancing the detection and management of acute hepatitis C virus infection
|
Martinello, Marianne
|
|
2015
|
|
10 |
p. 899-910
12 p.
|
artikel
|
| 5 |
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia
|
Treloar, Carla
|
|
2015
|
|
10 |
p. 992-998
7 p.
|
artikel
|
| 6 |
Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum
|
Meyer, Jaimie P.
|
|
2015
|
|
10 |
p. 922-935
14 p.
|
artikel
|
| 7 |
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
|
Grebely, Jason
|
|
2015
|
|
10 |
p. 893-898
6 p.
|
artikel
|
| 8 |
From principles to practice: Description of a novel equity-based HCV primary care treatment model for PWID
|
Milne, Rozalyn
|
|
2015
|
|
10 |
p. 1020-1027
8 p.
|
artikel
|
| 9 |
Health-Related Quality of Life for individuals with hepatitis C: A narrative review
|
Whiteley, David
|
|
2015
|
|
10 |
p. 936-949
14 p.
|
artikel
|
| 10 |
Hepatitis C transmission and treatment as prevention – The role of the injecting network
|
Hellard, Margaret
|
|
2015
|
|
10 |
p. 958-962
5 p.
|
artikel
|
| 11 |
Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis
|
Smith, Daniel J.
|
|
2015
|
|
10 |
p. 911-921
11 p.
|
artikel
|
| 12 |
Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention
|
Artenie, Andreea Adelina
|
|
2015
|
|
10 |
p. 970-975
6 p.
|
artikel
|
| 13 |
Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C
|
Alavi, Maryam
|
|
2015
|
|
10 |
p. 976-983
8 p.
|
artikel
|
| 14 |
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study
|
Marshall, A.D.
|
|
2015
|
|
10 |
p. 984-991
8 p.
|
artikel
|
| 15 |
Recommendations for the management of hepatitis C virus infection among people who inject drugs
|
Grebely, Jason
|
|
2015
|
|
10 |
p. 1028-1038
11 p.
|
artikel
|
| 16 |
Successful treatment of chronic hepatitis C with triple therapy in an opioid agonist treatment program
|
Litwin, Alain H.
|
|
2015
|
|
10 |
p. 1014-1019
6 p.
|
artikel
|
| 17 |
The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs?
|
Harris, Magdalena
|
|
2015
|
|
10 |
p. 963-969
7 p.
|
artikel
|
Tijdschrift beschrijving